Insider ownership feed
Showing Forms 3/4/5 accepted since 08 May 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
22,551
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/0
Positive/negative net value among the preview cards.
Visible net value
$0
Directional preview only; verify transaction rows and footnotes.
Newest evidence
05 Jun 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
Jeffrey L. Ives filed Form 4 for Acumen Pharmaceuticals, Inc. (ABOS). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Ara K. Hovnanian filed Form 4 for HOVNANIAN ENTERPRISES INC (HOV). Role/context: Chairman of the Board & CEO, Director, 10%+ Owner. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Adrian R. Krainer filed Form 4 for Stoke Therapeutics, Inc. (STOK). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Sharon L. Wienbar filed Form 4 for RESIDEO TECHNOLOGIES, INC. (REZI). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
George Golumbeski filed Form 4 for Acumen Pharmaceuticals, Inc. (ABOS). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Shawn Henry filed Form 4 for Clear Secure, Inc. (YOU). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | Jeffrey L. Ives CIK 0001614096 | $0 | 03 Jun 2026 | |
| HOV | HOVNANIAN ENTERPRISES INC | Ara K. Hovnanian CIK 0000938549 | $0 | 03 Jun 2026 | |
| STOK | Stoke Therapeutics, Inc. | Adrian R. Krainer CIK 0001780081 | $0 | 03 Jun 2026 | |
| REZI | RESIDEO TECHNOLOGIES, INC. | Sharon L. Wienbar CIK 0001393556 | $0 | 03 Jun 2026 | |
| ABOS | Acumen Pharmaceuticals, Inc. | George Golumbeski CIK 0001586660 | $0 | 03 Jun 2026 | |
| YOU | Clear Secure, Inc. | Shawn Henry CIK 0001808553 | $0 | 05 Jun 2026 | |
| GOSS | Gossamer Bio, Inc. | Sandra Milligan CIK 0001859810 | $0 | 04 Jun 2026 | |
| DNLI | Denali Therapeutics Inc. | BAKER BROS. ADVISORS LP CIK 0001263508 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Frank X. Leonard CIK 0001822879 | -$614,635 | 04 Jun 2026 | |
| STOK | Stoke Therapeutics, Inc. | Edward M. Kaye MD CIK 0001522780 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Gabriel Leung CIK 0001236183 | $0 | 03 Jun 2026 | |
| COCO | Vita Coco Company, Inc. | Ira Liran CIK 0001886269 | $0 | 03 Jun 2026 | |
| GOSS | Gossamer Bio, Inc. | Steven D. Nathan CIK 0002015114 | $0 | 04 Jun 2026 | |
| NVCR | NovoCure Ltd | Kristin Stafford CIK 0001970438 | $0 | 03 Jun 2026 | |
| ABOS | Acumen Pharmaceuticals, Inc. | Laura Stoppel CIK 0001865119 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Allyson J. Ocean CIK 0001967326 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Timothy J. Scannell CIK 0001451533 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Jeryl L. Hilleman CIK 0001216628 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | David Hung CIK 0001310880 | $0 | 03 Jun 2026 | |
| STOK | Stoke Therapeutics, Inc. | Seth Loring Harrison CIK 0001404955 | $0 | 03 Jun 2026 | |
| COCO | Vita Coco Company, Inc. | Jane Cecil Morreau CIK 0001259381 | $0 | 03 Jun 2026 | |
| NVCR | NovoCure Ltd | Martin J. Madden CIK 0001696864 | $0 | 03 Jun 2026 | |
| YOU | Clear Secure, Inc. | Tomago Collins CIK 0001585115 | $0 | 05 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Daniel Skovronsky CIK 0001741474 | $0 | 04 Jun 2026 | |
| NVCR | NovoCure Ltd | W. Anthony Vernon CIK 0001369091 | $0 | 03 Jun 2026 | |
| DUOL | Duolingo, Inc. | James H. Shelton CIK 0001342646 | $0 | 03 Jun 2026 | |
| DUOL | Duolingo, Inc. | Sara Clemens CIK 0001600681 | $0 | 03 Jun 2026 | |
| SANA | Sana Biotechnology, Inc. | Robert Nelsen CIK 0001219042 | $0 | 04 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Lee Nisley Newcomer CIK 0001788981 | $0 | 04 Jun 2026 | |
| PMVP | PMV Pharmaceuticals, Inc. | Carol Giltner Gallagher CIK 0001329959 | $0 | 04 Jun 2026 | |
| DUOL | Duolingo, Inc. | Amy Bohutinsky CIK 0001524315 | $0 | 03 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Mark S. Davis CIK 0002024613 | $0 | 04 Jun 2026 | |
| DUOL | Duolingo, Inc. | John Osborne Lilly III CIK 0001897305 | $0 | 03 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | S. Louise Phanstiel CIK 0001471518 | $0 | 04 Jun 2026 | |
| DUOL | Duolingo, Inc. | William B. Gordon CIK 0001229590 | $0 | 03 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Heinrich Dreismann CIK 0001379372 | $0 | 04 Jun 2026 | |
| ASMB | ASSEMBLY BIOSCIENCES, INC. | Jeanette M. Bjorkquist CIK 0001945064 | $0 | 29 Mar 2026 | |
| MYGN | MYRIAD GENETICS INC | Colleen F. Reitan CIK 0001740730 | $0 | 04 Jun 2026 | |
| DUOL | Duolingo, Inc. | Mario Schlosser CIK 0001844320 | $0 | 03 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Paul Bisaro CIK 0001237253 | $0 | 04 Jun 2026 | |
| DUOL | Duolingo, Inc. | Bonnie Ross CIK 0002046989 | $0 | 03 Jun 2026 | |
| MYGN | MYRIAD GENETICS INC | Rashmi Kumar CIK 0001824720 | $0 | 04 Jun 2026 | |
| COCO | Vita Coco Company, Inc. | Kenneth Sadowsky CIK 0001886372 | $0 | 03 Jun 2026 | |
| STOK | Stoke Therapeutics, Inc. | Jennifer Burstein CIK 0001640069 | $0 | 03 Jun 2026 | |
| REZI | RESIDEO TECHNOLOGIES, INC. | Kareem Yusuf CIK 0001850377 | $0 | 03 Jun 2026 | |
| AXTI | AXT INC | Jesse Chen CIK 0001268534 | -$1,109,514 | 03 Jun 2026 | |
| REZI | RESIDEO TECHNOLOGIES, INC. | Brian G. Kushner CIK 0001728934 | $0 | 03 Jun 2026 | |
| PMVP | PMV Pharmaceuticals, Inc. | Kirsten Flowers CIK 0001797209 | $0 | 04 Jun 2026 | |
| REZI | RESIDEO TECHNOLOGIES, INC. | Nina L. Richardson CIK 0001610535 | $0 | 03 Jun 2026 | |
| MAX | MediaAlpha, Inc. | Kuanling Amy Yeh CIK 0001829969 | -$26,669 | 05 Jun 2026 |